Ophthalmologic Approach to Chemical Burns Clinical Presentation

  • Author: J Bradley Randleman, MD; Chief Editor: Hampton Roy Sr, MD   more...
 
Updated: Feb 7, 2011
 

History

Most often, the patient gives a history of a liquid or a gas being splashed or sprayed into the eyes or of particles falling into the eyes. Query the patient regarding the specific nature of the chemical and the mechanism of injury (eg, simple splash vs high-velocity blast). The local poison control center can be an invaluable resource in determining the exact nature of the chemical when unknown.

Regardless of the specific mechanism of injury, the patient's complaints are frequently related to the severity of the exposure. Common complaints elicited are as follows:

Next

Physical

A thorough physical examination should be deferred until the affected eye is irrigated copiously, and the pH of the ocular surface is neutralized. Topical anesthetic drops may be used to aid in patient comfort and cooperation. After irrigation, a thorough eye examination is performed with special attention given to clarity and integrity of the cornea, degree of limbal ischemia, and IOP. Common physical manifestations of chemical injuries to the eye include the following:

  • Decreased visual acuity: Initial visual acuity can be decreased because of corneal epithelial defects, haze, increased lacrimation, or discomfort. In moderate-to-severe chemical burns seen soon after the injury, the corneal haze may be minimal on presentation with good vision, but it can increase significantly with time, severely reducing vision.
  • Increased IOP: An immediate rise in IOP may result from collagen deformation and shortening, thereby shrinking the anterior chamber. Prolonged elevation of IOP is directly related to the degree of anterior segment inflammation.
  • Conjunctival inflammation: Varying degrees of conjunctival hyperemia and chemosis are possible, and even a mild chemical injury can elicit an exuberant conjunctival response.
  • Particles in the conjunctival fornices: This finding is more common with particulate injuries, such as plaster. If not removed, the residual particles can serve as a reservoir for continued chemical release and injury. These particles must be removed before ocular surface healing can begin.
  • Perilimbal ischemia: The degree of limbal ischemia (blanching) is perhaps the most significant prognostic indicator for future corneal healing because the limbal stem cells are responsible for repopulating the corneal epithelium. In general, the greater the extent of blanching, the worse the prognosis. However, the presence of intact perilimbal stem cells does not guarantee normal epithelial healing. The extent of blanching should be documented in terms of clock hours involved.
  • Corneal epithelial defect: Corneal epithelial damage can range from mild diffuse punctate epithelial keratitis (PEK) to a complete epithelial defect. A complete epithelial defect may not take up fluorescein dye as rapidly as in a routine corneal abrasion; therefore, it may be missed. If an epithelial defect is suspected but not found on the initial evaluation, the eye should be reexamined after several minutes. The size of the defect should be recorded so as to document response to treatment on subsequent visits.
  • Stromal haze: Haze can range from a clear cornea (grade 0) to a complete opacification (grade 5) with no view into the anterior chamber.
  • Corneal perforation: A very rare finding at presentation, it is more likely to occur after the initial presentation (from days to weeks) in severely injured eyes that have poor healing capacity.
  • Anterior chamber inflammatory reaction: This can vary from trace cell and flare to a vigorous fibrinoid anterior chamber reaction. Generally, this finding is more common with alkaline injuries because of the greater depth of penetration.
  • Adnexal damage/scarring: Similar to chemical injuries on other skin areas, this finding can lead to severe exposure problems if eyelid scarring prevents proper closure, thereby exposing an already damaged ocular surface.
Previous
Next

Causes

Common sources of alkali are as follows:[9]

  • Cleaning products (eg, ammonia)
  • Fertilizers (eg, ammonia)
  • Drain cleaners (eg, lye)
  • Cement, plaster, mortar (eg, lime)
  • Airbag rupture (eg, sodium hydroxide)
  • Fireworks (eg, magnesium hydroxide)
  • Potash (eg, potassium hydroxide)

Common sources of acids are as follows:[9]

  • Battery acid (eg, sulfuric acid)
  • Bleach (eg, sulfurous acid)
  • Glass polish (eg, hydrofluoric; behaves like alkali)
  • Vinegar (eg, acetic acid)
  • Chromic acid (brown discoloration of conjunctiva)
  • Nitric acid (yellow discoloration of conjunctiva)
  • Hydrochloric acid
Previous
 
 
Contributor Information and Disclosures
Author

J Bradley Randleman, MD  Associate Professor, Department of Ophthalmology, Section of Cornea, External Disease and Refractive Surgery, Emory University School of Medicine; Director of Cornea, External Disease and Refractive Surgery Fellowship, Emory University; Physician Member, Section of Ophthalmology, The Emory Clinic

J Bradley Randleman, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Ophthalmology, American Society of Cataract and Refractive Surgery, Cornea Society, and International Society of Refractive Surgery

Disclosure: Nothing to disclose.

Coauthor(s)

Alok S Bansal, MD  Resident Physician, Emory Eye Center

Alok S Bansal, MD is a member of the following medical societies: American Academy of Ophthalmology, American Society of Cataract and Refractive Surgery, Association for Research in Vision and Ophthalmology, and International Society of Refractive Surgery

Disclosure: Nothing to disclose.

Evan S Loft  MD, Clinical Assistant Professor, Department of Ophthalmology, Emory University

Evan S Loft is a member of the following medical societies: American Academy of Ophthalmology, American Medical Association, American Society of Cataract and Refractive Surgery, Association for Research in Vision and Ophthalmology, and Phi Beta Kappa

Disclosure: Nothing to disclose.

Geoffrey Broocker, FACS, MD  Walthour-DeLaPerriere Professor of Ophthalmology, Department of Ophthalmology, Emory University School of MedicineChief of Service, Ophthalmology, Grady Memorial Hospital

Geoffrey Broocker, FACS, MD is a member of the following medical societies: American College of Surgeons

Disclosure: Nothing to disclose.

Specialty Editor Board

Fernando H Murillo-Lopez, MD  Senior Surgeon, Unidad Privada de Oftalmologia CEMES

Fernando H Murillo-Lopez, MD is a member of the following medical societies: American Academy of Ophthalmology

Disclosure: Nothing to disclose.

Simon K Law, MD, PharmD  Associate Professor of Ophthalmology, Jules Stein Eye Institute, University of California, Los Angeles, David Geffen School of Medicine

Simon K Law, MD, PharmD is a member of the following medical societies: American Academy of Ophthalmology, American Glaucoma Society, and Association for Research in Vision and Ophthalmology

Disclosure: Nothing to disclose.

Christopher J Rapuano, MD  Professor, Department of Ophthalmology, Jefferson Medical College of Thomas Jefferson University; Director of the Cornea Service, Co-Director of Refractive Surgery Department, Wills Eye Institute

Christopher J Rapuano, MD is a member of the following medical societies: American Academy of Ophthalmology, American Society of Cataract and Refractive Surgery, Contact Lens Association of Ophthalmologists, Cornea Society, Eye Bank Association of America, International Society of Refractive Surgery, and Pan-American Association of Ophthalmology

Disclosure: Allergan Honoraria Speaking and teaching; Allergan Consulting fee Consulting; Alcon Honoraria Speaking and teaching; Inspire Honoraria Speaking and teaching; RPS Ownership interest Other; Vistakon Honoraria Speaking and teaching; EyeGate Pharma Consulting; Inspire Consulting fee Consulting; Bausch & Lomb Honoraria Speaking and teaching; Bausch & Lomb Consulting fee Consulting

Lance L Brown, OD, MD  Ophthalmologist, Affiliated With Freeman Hospital and St John's Hospital, Regional Eye Center, Joplin, Missouri

Disclosure: Nothing to disclose.

Chief Editor

Hampton Roy Sr, MD  Associate Clinical Professor, Department of Ophthalmology, University of Arkansas for Medical Sciences

Hampton Roy Sr, MD is a member of the following medical societies: American Academy of Ophthalmology, American College of Surgeons, and Pan-American Association of Ophthalmology

Disclosure: Nothing to disclose.

References
  1. Merle H, Gerard M, Schrage N. [Ocular burns]. J Fr Ophtalmol. Sep 2008;31(7):723-34. [Medline].

  2. Hodge C, Lawless M. Ocular emergencies. Aust Fam Physician. Jul 2008;37(7):506-9. [Medline].

  3. Spector J, Fernandez WG. Chemical, thermal, and biological ocular exposures. Emerg Med Clin North Am. Feb 2008;26(1):125-36, vii. [Medline].

  4. Pfister DA, Pfister RR. Acid injuries of the eye. Fundamentals of Cornea and External Disease. Cornea. Vol 2. 2005:1277-84.

  5. Pfister RR, Pfister DA. Alkali injuries of the eye. In: Fundamentals of Cornea and External Disease. Cornea. Vol 2. 2005:1285-93.

  6. Xiang H, Stallones L, Chen G, Smith GA. Work-related eye injuries treated in hospital emergency departments in the US. Am J Ind Med. Jul 2005;48(1):57-62. [Medline].

  7. Morgan SJ. Chemical burns of the eye: causes and management. Br J Ophthalmol. Nov 1987;71(11):854-7. [Medline].

  8. Klein R, Lobes LA Jr. Ocular alkali burns in a large urban area. Ann Ophthalmol. Oct 1976;8(10):1185-9. [Medline].

  9. Wagoner MD, Kenyon KR. Chemical injuries of the eye. Clinical Practice. In: Albert, Jakobiec, eds. Principles and Practice of Ophthalmology. Vol 2. 2000:943-59.

  10. Kheirkhah A, Johnson DA, Paranjpe DR, Raju VK, Casas V, Tseng SC. Temporary sutureless amniotic membrane patch for acute alkaline burns. Arch Ophthalmol. Aug 2008;126(8):1059-66. [Medline].

  11. Tandon R, Gupta N, Kalaivani M, et al. Amniotic membrane transplantation as an adjunct to medical therapy in acute ocular burns. Br J Ophthalmol. Feb 2011;95(2):199-204. [Medline].

  12. Brodovsky SC, McCarty CA, Snibson G, et al. Management of alkali burns : an 11-year retrospective review. Ophthalmology. Oct 2000;107(10):1829-35. [Medline].

  13. Kheirkhah A, Johnson DA, Paranjpe DR, Raju VK, Casas V, Tseng SC. Temporary sutureless amniotic membrane patch for acute alkaline burns. Arch Ophthalmol. Aug 2008;126(8):1059-66. [Medline].

  14. Kawashima M, Kawakita T, Satake Y, Higa K, Shimazaki J. Phenotypic study after cultivated limbal epithelial transplantation for limbal stem cell deficiency. Arch Ophthalmol. Oct 2007;125(10):1337-44. [Medline].

  15. Tuft SJ, Shortt AJ. Surgical rehabilitation following severe ocular burns. Eye. Jan 23 2009;[Medline].

  16. Dua HS, King AJ, Joseph A. A new classification of ocular surface burns. Br J Ophthalmol. Nov 2001;85(11):1379-83. [Medline].

Previous
Next
 
Alkali burn. Note the severe conjunctival reaction and stromal opacification blurring iris details inferiorly.
Severe chemical injury with early corneal neovascularization.
Complete cicatrization of the corneal surface following chemical injury.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.